PF-07934040
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-07934040, covering 2026-04-20 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation. [Phase 1]